Ilsung Is Co., Ltd. (KRX:003120)
15,260
-70 (-0.46%)
Last updated: Mar 27, 2025
Ilsung Is Revenue
In the year 2024, Ilsung Is had annual revenue of 69.02B KRW, down -11.58%. Ilsung Is had revenue of 16.87B in the quarter ending December 31, 2024, a decrease of -23.39%.
Revenue
69.02B
Revenue Growth
-11.58%
P/S Ratio
1.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
106.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 69.02B | -9.03B | -11.58% |
Dec 31, 2023 | 78.05B | 16.81B | 27.44% |
Dec 31, 2022 | 61.25B | 19.16B | 45.52% |
Dec 31, 2021 | 42.09B | 1.49B | 3.67% |
Dec 31, 2020 | 40.60B | -7.81B | -16.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |